Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.

Lieve G J Leijssen Anne M Dinaux Ramzi AmriMartin S TaylorVikram DeshpandeLiliana G BordeianouHiroko KunitakeDavid L Berger

Published in: Journal of surgical oncology (2019)

EMVI is a strong predictor for worse oncologic outcomes in stage II-III colon cancer patients, whereas IMVI is not. It is also associated with worse outcomes compared in patients with higher stage disease who are EMVI negative.

Keyphrases

prostate cancer
type diabetes
metabolic syndrome
glycemic control
robot assisted